PDCD1 and Pruritus: Finally, since head-to-head comparison of PD-1/PD-L1 inhibitor combination therapies and PD-1/PD-L1 inhibitor alone were not available, we used the relative risk ratio (RRR) to indirectly compare the risk of pruritus and rash.